TSS
BOLT icon

Two Sigma Securities’s Bolt Biotherapeutics BOLT Stock Holding History

Two Sigma Securities’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,275
Closed -$16.5K – 1799
2024
Q3 		$16.5K Sell
1,275
-1,419
-53% -$19.6K ﹤0.01% 2526
2024
Q2 		$40.4K Buy
2,694
+1,503
+126% +$29.7K ﹤0.01% 2597
2024
Q1 		$33.3K Sell
1,191
-2,021
-63% -$46.8K ﹤0.01% 2618
2023
Q4 		$71.9K Buy
+3,212
New +$62.5K ﹤0.01% 2557

Other funds holding BOLT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Securities's BOLT Position: Q4 2024 in Review

Two Sigma Securities sold out of Bolt Biotherapeutics (BOLT) in Q4 2024, closing a stake of 1,275 shares — an estimated $16.5K sold.

Two Sigma Securities first reported a position in BOLT in Q4 2023 and held it in 4 quarters. The position peaked at $71.9K in Q4 2023. 37 funds tracked by Wall St. Rank hold BOLT as of Q4 2024.

  • Two Sigma Securities reported no remaining Bolt Biotherapeutics position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Securities sold 1,275 Bolt Biotherapeutics shares in Q4 2024, an estimated $16.5K.
  • Two Sigma Securities first reported a position in Bolt Biotherapeutics in Q4 2023 and held it in 4 quarters.
  • Two Sigma Securities's Bolt Biotherapeutics position peaked at $71.9K in Q4 2023.
  • 37 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q4 2024.

Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.